OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
<h4>Background</h4>Hospitalization for acute decompensated heart failure (ADHF) remains a major source of morbidity and mortality. The current study aimed to investigate the feasibility, safety, and efficacy of outpatient furosemide intravenous (IV) infusion following hospitalization for...
Guardado en:
Autores principales: | Carine E Hamo, Sahar S Abdelmoneim, Seol Young Han, Elizabeth Chandy, Cornelia Muntean, Saadat A Khan, Prasanthi Sunkesula, Marcella Meykler, Vidhya Ramachandran, Emelie Rosenberg, Igor Klem, Terrence J Sacchi, John F Heitner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7155278062741abb30edd606c7a0dc4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management options in decompensated cirrhosis
por: Shah NL, et al.
Publicado: (2015) -
Role of Levosimendan in acute decompensated heart failure
por: V.K. Katyal, et al.
Publicado: (2021) -
Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
por: Kurt Grüngreiff, et al.
Publicado: (2021) -
Prognostic impact of uric acid in patients with acute decompensated heart failure
por: Svetlana N. Nasonova, et al.
Publicado: (2021) -
La crise organique comme décompensation du corps capitaliste : Gramsci et Spinoza
por: Frédéric Lordon
Publicado: (2021)